These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15960941)

  • 1. [Selective cholesterol absorption inhibition as a new prospect in treatment of hypercholesterolemia].
    Lima J; Fonollosa V; Chacón P
    Med Clin (Barc); 2005 Jun; 125(1):16-23. PubMed ID: 15960941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe: a selective cholesterol absorption inhibitor.
    Nutescu EA; Shapiro NL
    Pharmacotherapy; 2003 Nov; 23(11):1463-74. PubMed ID: 14620392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor.
    Jeu L; Cheng JW
    Clin Ther; 2003 Sep; 25(9):2352-87. PubMed ID: 14604738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe.
    Bays H
    Expert Opin Investig Drugs; 2002 Nov; 11(11):1587-604. PubMed ID: 12437505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe: rationale and role in the management of hypercholesterolemia.
    Yatskar L; Fisher EA; Schwartzbard A
    Clin Cardiol; 2006 Feb; 29(2):52-5. PubMed ID: 16506638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ezetimibe: from pharmacology to clinical trials].
    Tellier P
    Ann Endocrinol (Paris); 2003 Dec; 64(6):442-7. PubMed ID: 15067249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.
    Patel SB
    Curr Cardiol Rep; 2004 Nov; 6(6):439-42. PubMed ID: 15485605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors.
    Gupta EK; Ito MK
    Heart Dis; 2002; 4(6):399-409. PubMed ID: 12441019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe in hypercholesterolaemia.
    Farnier M
    Int J Clin Pract; 2002 Oct; 56(8):611-4. PubMed ID: 12425372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe, a selective inhibitor of the transport of cholesterol.
    Miura S; Saku K
    Intern Med; 2008; 47(13):1165-70. PubMed ID: 18591835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic therapy and cholesterol absorption.
    Manhas A; Farmer JA
    Curr Atheroscler Rep; 2004 Mar; 6(2):89-93. PubMed ID: 15023291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
    Sudhop T; Lütjohann D; Kodal A; Igel M; Tribble DL; Shah S; Perevozskaya I; von Bergmann K
    Circulation; 2002 Oct; 106(15):1943-8. PubMed ID: 12370217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 17. Ezetimibe.
    Darkes MJ; Poole RM; Goa KL
    Am J Cardiovasc Drugs; 2003; 3(1):67-76; discussion 77-8. PubMed ID: 14727947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Sweeney ME; Johnson RR
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):441-50. PubMed ID: 17539750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe (Schering-Plough).
    Meng CQ
    Curr Opin Investig Drugs; 2001 Mar; 2(3):389-92. PubMed ID: 11575710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.